Tracon Pharmaceuticals, Inc. 4
4 · Tracon Pharmaceuticals, Inc. · Filed Sep 22, 2015
Insider Transaction Report
Form 4
LOGAN H CASEY
Chief Business Officer
Transactions
- Sale
Common Stock
2015-09-18$17.34/sh−5,000$86,700→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-09-18−5,000→ 80,270 totalExercise: $1.34Exp: 2023-03-13→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-09-18$1.34/sh+5,000$6,700→ 5,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2015
- [F2]1/4 of the shares subject to the option vested on February 19, 2014, and the remaining shares vest in 36 equal monthly installments thereafter.